RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
اقرأ هذه الصفحة بـ: English · العربية · Français · Português
Register / South Africa / DEA-ZA-2022-50423430
South African Health Products Regulatory Authority · South Africa
DEA-ZA-2022-50423430
Tier 1 · Regulator-publishedClass IIIسحبStatus · active
Authority reference
Not stated by the issuing authority
Date issued
28 Jan 2022SAHPRA heads this column "Date Updated" rather than the date of the recall.
Recorded by us
2026-09-06 20:25:58 UTC
المستحضر
Oranix Solution (oral rinse) (Benzydamine HCl 22,5 mg/15 ml; Chlorhexidine gluconate 18,0 mg/15 ml)
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
الشركة المصنعة
iNova Pharmaceuticals (Pty) Ltd
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
أرقام التشغيلات
126189
تواريخ انتهاء الصلاحية
Not published with the notice
Action type
سحب
التصنيف
Class III as issued
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Not stated by the issuing authority
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
South Africa — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
نص الإخطار
Not captured. The notice itself is linked below.
الحالة
سارٍ
Superseded by
Not superseded. This is the current version.
Version
12

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
f1dad60ae38ff5a7639c2f5e2ee2147e6aa72987ded2f80289219f864915adec
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-06 20:52:26 UTC
Cite this record
Drug Eye Africa (2022). DEA-ZA-2022-50423430: Oranix Solution (oral rinse) (Benzydamine HCl 22,5 mg/15 ml; Chlorhexidine gluconate 18,0 mg/15 ml) — سحب, South African Health Products Regulatory Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/za/2022/dea-za-2022-50423430

Version history

No version history recorded for this record.
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.